CASI
CASI Pharmaceuticals Inc
NASDAQ: CASI · HEALTHCARE · BIOTECHNOLOGY
$0.21
+0.00% today
Updated 2026-04-29
Market cap
$3.21M
P/E ratio
—
P/S ratio
0.12x
EPS (TTM)
$-3.02
Dividend yield
—
52W range
$0 – $3
Volume
1.0M
CASI Pharmaceuticals Inc (CASI) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.92M | $6.89M | $7.40M | $7.48M | $5.28M | $3.69M | $1.94M | $669310.00 | $0.00 | $23727.00 | $47712.00 | $0.00 | $0.00 | $0.00 | $4.13M | $15.14M | $30.17M | $43.11M | $33.88M | $28.54M |
| Revenue growth (YoY) | — | +16.5% | +7.3% | +1.1% | -29.3% | -30.1% | -47.4% | -65.5% | -100.0% | — | +101.1% | -100.0% | — | — | — | +266.5% | +99.2% | +42.9% | -21.4% | -15.8% |
| Cost of revenue | $22.77M | $28.62M | $30.79M | $25.77M | $11.65M | $8.16M | $6.47M | $5.15M | $0.00 | $7467.00 | $6274.00 | $66451.00 | $117779.00 | $1.67M | $3.94M | $9.51M | $12.56M | $15.83M | $13.83M | $17.39M |
| Gross profit | $5.92M | $6.89M | $7.40M | $7.48M | $5.28M | $3.69M | $1.94M | $669310.00 | $0.00 | $16260.00 | $41438.00 | $-66451.00 | $-117779.00 | $-1.67M | $196000.00 | $5.63M | $17.61M | $27.28M | $20.05M | $11.15M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | — | 68.5% | 86.9% | — | — | — | 4.7% | 37.2% | 58.4% | 63.3% | 59.2% | 39.1% |
| R&D | $17.33M | $21.67M | $23.74M | $20.07M | $7.90M | $4.83M | $3.46M | $2.38M | $2.75M | $2.77M | $4.08M | $4.65M | $7.60M | $8.51M | $9.75M | $11.47M | $14.42M | $16.00M | $9.86M | $8.92M |
| SG&A | $5.92M | $7.39M | $7.39M | $7.76M | $4.10M | $3.40M | $3.05M | $2.80M | $2.99M | $3.76M | $3.12M | $4.78M | $3.16M | $18.00M | $27.34M | $19.66M | $23.70M | $23.45M | $25.39M | $23.58M |
| Operating income | $17.33M | $51.65M | $23.73M | $22.36M | $6.72M | $-4.53M | $-4.57M | $4.50M | $5.74M | $26.19M | $7.15M | $9.42M | $-10.75M | $-26.50M | $-39.99M | $-52.78M | $-41.52M | $-26.49M | $-25.08M | $-39.62M |
| Operating margin | 292.8% | 749.2% | 320.9% | 299.0% | 127.2% | -122.8% | -235.4% | 672.9% | — | 110370.0% | 14990.8% | — | — | — | -968.1% | -348.6% | -137.6% | -61.5% | -74.0% | -138.8% |
| EBITDA | $-15.84M | $-22.64M | $-21.28M | $-21.33M | $-6.63M | $-4.46M | $-4.52M | $-4.48M | $-5.72M | $-26.13M | $-7.06M | $-9.35M | $-10.64M | $-25.79M | $-37.43M | $-31.35M | $-33.40M | $-24.07M | $-21.54M | $-34.87M |
| EBITDA margin | -267.6% | -328.4% | -287.8% | -285.2% | -125.4% | -120.9% | -232.9% | -669.9% | — | -110111.1% | -14787.9% | — | — | — | -906.1% | -207.1% | -110.7% | -55.8% | -63.6% | -122.2% |
| EBIT | $-15.99M | $-22.17M | $-20.50M | $-21.65M | $-6.72M | $-4.53M | $-4.56M | $-4.50M | $-5.74M | $-26.17M | $-7.12M | $-9.42M | $-10.76M | $-27.46M | $-39.58M | $-33.31M | $-35.22M | $-26.49M | $-25.28M | $-37.20M |
| Interest expense | $0.00 | $156787.00 | $793393.00 | $2.22M | $1.49M | $540218.00 | $0.00 | $10.04M | $1658.00 | $28064.00 | $82455.00 | $33808.00 | $14976.00 | $8208.00 | $1.06M | $0.00 | $6.00M | $62000.00 | $15000.00 | $871000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-16.31M | $-49.89M | $-22.41M | $-23.86M | $-8.22M | $-8.10M | $-4.56M | $-14.55M | $-5.74M | $-26.20M | $-7.21M | $-9.45M | $-10.77M | $-27.47M | $-45.36M | $-48.29M | $-36.65M | $-41.01M | $-26.94M | $-39.26M |
| Net income growth (YoY) | — | -205.8% | +55.1% | -6.5% | +65.6% | +1.4% | +43.7% | -219.1% | +60.5% | -356.6% | +72.5% | -31.2% | -13.9% | -155.1% | -65.1% | -6.4% | +24.1% | -11.9% | +34.3% | -45.7% |
| Profit margin | -275.7% | -723.6% | -303.0% | -319.1% | -155.5% | -219.4% | -234.9% | -2173.2% | — | -110432.5% | -15104.0% | — | — | — | -1098.1% | -318.9% | -121.5% | -95.1% | -79.5% | -137.6% |